Author/Authors :
Shidfar, F. iran university of medical sciences - School of Health - Department of Nutrition, تهران, ايران , Keshavarz, A. School of Health - Department of Nutrition, ايران , Hosseyni, S. islamic azad university - Department of Chemistry, ايران , Ameri, A. iran university of medical sciences - School of Health - Department of Health, تهران, ايران , Yarahmadi, S. tehran university of medical sciences tums - School of Medicine - Department of Endocrinology, تهران, ايران
Abstract :
In order to test whether hyperlipidaemia and glycaemic control can be improved among diabetes patients by dietary supplementation with purified omega-3 fatty acids, we carried out a dubleblind, placebo-controlled trial on 50 type 2 diabetes patients randomized to 2 g/day purified omega-3 fatty acids or placebo for 10 weeks. Fasting triglycerides decreased significantly with supplementation relative to placebo (P = 0.01). There was a significant decrease in ApoB-100 and malondialdehyde compared to baseline values and compared to the control group. Omega-3 fatty acids had no significant effect on serum lipid levels, ApoA-I, glucose, insulin and HbA1c.
